Rockwell Medical Inc logo

Rockwell Medical Inc

$ 1.34 +0.015 (+1.14%) 10:04 AM EST
P/E:
At Loss
P/B:
0.63
Market Cap:
$ 14.25M
Enterprise V:
$ 7.36M
Volume:
1.07K
Avg Vol (2M):
98.92K
Also Trade In:
Volume:
1.07K
Market Cap $:
14.25M
PE Ratio:
At Loss
Avg Vol (2-Month):
98.92K
Enterprise Value $:
7.36M
PB Ratio:
0.63
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Rockwell Medical Inc is a US-based fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease with its products and services for the treatment of iron deficiency, and hemodialysis. The company's drug products are Triferic. Triferic is a therapy indicated to replace iron and maintain hemoglobin in adult hemodialysis patients with chronic kidney disease. The company operates in one segment of the hemodialysis market which involves the exports, manufacture, sale, and distribution of hemodialysis products. Key revenue is generated from the United States.
Name Current Vs Industry Vs History
Cash-To-Debt 1.29
Equity-to-Asset 0.34
Debt-to-Equity 1.19
Debt-to-EBITDA -1
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -8.61
Distress
Grey
Safe
Beneish M-Score -2.51
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 36.23
9-Day RSI 35.04
14-Day RSI 38.84
6-1 Month Momentum % -72.46
12-1 Month Momentum % -79.66

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.55
Quick Ratio 2.27
Cash Ratio 1.66
Days Inventory 25.31
Days Sales Outstanding 35.9
Days Payable 22.28

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -18.1

Financials (Next Earnings Date:2022-11-15 Est.)

RMTI's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:RMTI

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 66.126
EPS (TTM) ($) -3.27
Beta 1.05
Volatility % 87.89
14-Day RSI 38.84
14-Day ATR ($) 0.132862
20-Day SMA ($) 1.52375
12-1 Month Momentum % -79.66
52-Week Range ($) 1.17 - 7.15
Shares Outstanding (Mil) 10.68

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Rockwell Medical Inc Filings

Document Form Filing Date
No Filing Data

Rockwell Medical Inc Analysis

Share your research

Headlines

See More
No news.